Discordant expression of perforin and granzyme A in total and HIV-specific CD8 T lymphocytes of HIV infected children and adolescents

AIDS

Volumn 17, Issue 16, 2003, Pages 2313-2322

  Haridas, Viraga ^a   McCloskey, Thomas W ^a   Pahwa, Rajendra ^a   Pahwa, Savita ^a  

^a NY University School of Medicine ^*  (United States)

Author keywords

CD27; Granzyme; HIV specific responses; Pediatric HIV AIDS; Perforin

Indexed keywords

BIOLOGICAL MARKER; CD27 ANTIGEN; CD8 ANTIGEN; GAG PROTEIN; GRANZYME A; HLA A2 ANTIGEN; PERFORIN; POL PROTEIN; TETRAMER;

ADOLESCENCE; ADOLESCENT; ADULT; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; BINDING ASSAY; CELL DIFFERENTIATION; CELL POPULATION; CELL SPECIFICITY; CHILD; CHILDHOOD; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; EFFECTOR CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOREGULATION; INFANT; MALE; PEDIATRICS; PERINATAL INFECTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; T LYMPHOCYTE; VIRUS LOAD;

ADOLESCENT; AGING; ANTIGENS, CD27; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CHILD; CHILD, PRESCHOOL; GRANZYMES; HIV INFECTIONS; HUMANS; INFANT; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; PORE FORMING CYTOTOXIC PROTEINS; SERINE ENDOPEPTIDASES; T-LYMPHOCYTE SUBSETS; VIRAL LOAD;

EID: 0742269876     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200311070-00005     Document Type: Article

References (39)

1. Murali-Krishna K, Altman JD, Suresh M, Sourdive DJ, Zajac AJ, Miller JD, et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 1998, 8:177-187.
2. Harrer T, Harrer E, Kalams SA, Barbosa P, Trocha A, Johnson RP, et al. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasi species in a person with prolonged infection and low viral load. J Immunol 1996, 156:2616-2613.
3. Propato A, Schiaffella E, Vicenzi E, Francavilla V, Baloni L, Paroli M, et al. Spreading of HIV-specific CD8+ T-cell repertoire in long-term nonprogressors and its role in the control of viral load and disease activity. Hum Immunol 2001, 62:561-576.
4. Klein MR, van Baalen CA, Holwerda AM, Kerkhof Garde SR, Bende RJ, Keet IP, et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med 1995, 181:1365-1372.
5. Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 1997, 278: 1447-1450.
6. McMichael AJ, Rowland-Jones SL. Cellular immmune responses to HIV. Nature 2001, 410:980-987.
7. Lieberman J, Shankar P, Manjunath N, Andersson J. Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood 2001, 98:1667-1677.
8. Musey L, Hughes J, Schacker T, Shea T, Corey L, McElrath MJ. Cytotoxic T cell responses, viral load and disease progression in early human immunodeficiency virus type 1 infection. New Engl J Med 1997, 337:1267-1274.
9. Hamann D, Baars PA, Rep MH, Hooibrink B, Kerfhof-Garde SR, Klein MR, et al. Phenotypic and functional separation of memory and effector human CD8 +T cells. J Exp Med 1997, 186: 1407-1418.
10. Kagi D, Lederman B, Burki K, Zinkernagel RM, Hengartner H. Lymphocyte-mediated cytotoxicity in vitro and in vivo: Mechanisms and significance. Immunol Rev 1995, 146:95-99.
11. Pinkoski M. Entry and trafficking of granzyme B in target cells during granzyme B-perforin mediated apoptosis. Blood 1998, 92:1044-1054.
12. Barry M, Bleackley RC. Cytotoxic T lymphocytes; all roads lead to death. Nature Rev Immunol 2002, 2:401-409.
13. Chen G, Shankar P, Lange C Valdez H, Skolnik PR, Wu L,, et al. CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection. Blood 2001, 98.156-164.
14. Appay V, Nixon DE, Donahoe SM, Gillespie GM, Dong T, King A, et al. HIV-specific CD8 + T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 2000, 192: 63-75.
15. Luzuriaga K, Holmes D, Hareema A, Wong J, Panicali DL, Sullivan JL. HIV-1 specific cytotoxic T responses in the first year of life. J Immunol 1995, 154:433-443.
16. McCloskey TW, Haridas V, Pahwa R, Pahwa S. Human immuno-deficiency virus gag and pol specific CD8 T cells in perinatal HIV infection. Cytometry (Commun Clin Cytometry) 2001, 46:265-270.
17. Scott-Algara D, Buseyne F, Blanche S, Riuzioux C, Romagne JF, Riviere Y. Frequency and phenotyping of HIV-specific CD8+ T cells in HIV-infected children, using major hisocompatibility complex class I peptide tetramers. J Infect Dis 2001, 183: 1565-1573.
18. Goepfert PA, Bansal A, Edwards BH, Ritter GD Jr, Tellez I, McPherson SA, et al. A significant number of human Immunodeficiency virus epitope specific cytotoxic T lymphocytes detected by tetramer binding do not reproduce gamma interferon. J Virol 2000, 74:10249-10255.
19. Kostense S, Vandenberghe K, Joling J, Van Baarle D, Nanlohy N, Manting E, et al. Persistent numbers of tetramer+ CD8+ T cells, but loss of IFNγ+ HIV-specific T cells during progression to AIDS. Eur J Immunol 2001, 31:677-686.
20. McCloskey TW, Kohn N, Lesser M, Bakshi S, Pahwa S. Immunophenotypic analysis of HIV-infected children: Alterations within the first year of life, changes with disease progression, and longitudinal analyses of lymphocyte subsets. Cytometry (Commun Clin Cytometry) 2001, 46:157-165.
21. Hamann D, Roos MTL, van Lier RAW. Faces and phases of human CD8+T-cell development. Immunol Today 1999, 20: 177-180.
22. Hamann D, Kostense S, Wolthers KC, Otto SA, Baars PA, Miedema F, et al. Evidence that human CD8+CD45RA+CD27-cells are induced by antigen and evolve through extensive rounds of division. Int Immunol 1999, 11:1027-1033.
23. Barrs PA, Ribeiro Do Couto LM, Leusen JH, Hooibrink B, Kuiijpers TW, Lens SM, et al. Cytolytic mechanisms and expression of activation-regulating receptors on effector-type CD8+CD45RA+CD27-human T cells. J Immunol 2000, 165:1901-1907.
24. Greenough TC, Brettler DB, Somasundaran M, Panicali DL, Sullivan JL. Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: evidence supporting a protective role for CTL in vivo. J Infect Dis 1997, 176:118-125.
25. Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human Immuno-deficiency virus type 1 infection. J Virol 1994, 68:6103-6110.
26. Ogg GS, Jin X, Bonhoeffer S, Dunbar PR, Nowak MA, Monard S, et al. Quantitation of HIV-1 specific cytotoxic T lymphocytes and plasma viral RNA load. Science 1998, 279:2103-2106.
27. Trimble LA, Lieberman J. Circulating CD8 T lymphocytes in human immunodeficiency virus-infected individuals have impaired function and downmodulate CD3ζ, the signaling chain of the T-cell receptor complex. Blood 1998, 91:585-594.
28. Geertsma MF, van Wengen-Stevenhagen A, van Dam EM, Risberg K, Kroon FP, Groeneveld PH, et al. Decreased expression of ζ molecules by T lymphocytes is correlated with disease progression in human immunodeficiency virus-infected persons. J Infect Dis 1999, 180:649-658.
29. Trimble LA, Shankar P, Patterson M, Daily JP, Lieberman J. Human immunodeficiency virus specific CD8 T lympfocytes have down-modulated CD3ζ and CD28, key signaling molecules for T-cell activation. J Virol 2000, 74:7320-7330.
30. Andersson J, Behbahani H, Lieberman J, Connick E, Landay A, Patterson B, et al. Perform is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection. AIDS 1999, 13:1295-1303.
31. Champagne P, Ogg GS, King AS, Knabenhans C, Ellefsen K, Nobile M, et al. Skewed maturation of memory HIV-1 specific CD8 T lymphocytes. Nature 2001, 410:106-111.
32. Kostense S, Ogg GS, Manting EH, Gillespie G, Joling J, Vandenberghe K, et al. High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: evidence for impaired CTL effector function. Eur J Immunol 2001, 31:677-686.
33. Goulder PJ, Altfeld MA, Rosenberg ES, Nguyen T, Tang Y, Eldridge RL, et al. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J Exp Med 2001, 193:181-194.
34. Zhang D, Shankar P, Xu Z, Harnisch B, Chen G, Lange C, et al. Most antiviral CD8 T cells during chronic viral infection do not express high levels of perform and are not directly cytotoxic. Blood 2002 226-235.
35. Goulder PJ, Sewell A.K., Lalloo D.G., Price DA, Whelan JA, Evans J, et al. Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two HLA-identical siblings with HLA-A*0201 are influenced by epitope mutation. J Exp Med 1997, 185:1423-1433.
36. Gray CM, Lawrence J, Schapiro JM, Altman JD, Winters MA, Crompton M, et al. Frequency of class I restricted anti HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy. J Immunol 1999, 162:1780-1788.
37. Ho H-N, Hytlin LE, Mitsuyasu RT. Circulating HIV specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens. I Immunol 1993, 150:3070-3079.
38. Migueles SA, Laborico AC, Shupert WL, Sabbaghian MS, Rabin R, Hallahan CW, et al. HIV-specific CD8+T cell proliferation is coupled to perform expression and is maintained in nonprogressors. Nature Immunol 2002, 3:1061-1068.
39. Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, Papagno L, et al. Memory CD8+T cells vary in differentiation phenotype in different persistent virus infections. Nature Med 2002, 8:379-385.